Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.4/NV-22-009. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P17-GII.17/NV-22-010. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.4/NV-22-099. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-001. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-002. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P8-GII.8/NV-23-003. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-004. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-005. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GI.P5-GI.5/NV-23-006. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GI.P3-GI.3/NV-23-007
. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P7-GII.6/NV-23-008.
. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.10/NV-23-009.
. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P8-GII.8/NV-23-010.
. Material 10-20% fecal material in virus culture medium.
Infectious cell culture supernatant containing Human Parechovirus A6
(PEV-A6/Netherlands/10008/2014). This strain is preserved in viral storage medium -80°C.
"Infectious cell culture supernatant containing Human Parechovirus A4
(PEV-A4/Netherlands/10007/2014). This strain is preserved in viral storage medium -80°C."
"Infectious cell culture supernatant containing Coxsackievirus A9
(CV-A9/Netherlands/10000/2018). This strain is preserved in viral storage medium -80°C."
Infectious cell culture supernatant containing Human Parechovirus A5
(PEV-A5/Netherlands/10018/2014). This strain is preserved in viral storage medium -80°C.
"Infectious cell culture supernatant containing Coxsackievirus A6
(CV-A6/Netherlands/10014/1965). This strain is preserved in viral storage medium -80°C."
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strains, representing different genotypes. Strains/genotypes/year (2012-2023) selection on demand. Custom-made package includes individual fecal material from 5 different patients, 10-20% suspended in virus culture medium.
Service includes technical input on protocols and experiment design and support in the laboratory.
Individual questions to refine potential requests can be sent to [email protected].
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced sapovirus strains, representing different genotypes. Strains/genotypes/year (2012-2023) selection on demand. Custom-made package includes individual fecal material from 2 different patients, 10-20% suspended in virus culture medium.
Service includes technical input on protocols and experiment design and support in the laboratory.
Individual questions to refine potential requests can be sent to [email protected].
Tick-borne encephalitis virus (TBEV), subtype TBEV-Eu, divergent strain Salland (the Netherlands) rescued and cultured on BHK-21 cells as described in Hoornweg et al., Sci Rep. 2023 Feb 18;13(1):2872.
Purified recombinant SARS-CoV-2 BA.3 (B.1.1.529.3) Spike protein (trimerisation domain and C-terminal hexa histidine-tag) expressed in mammalian HEK293F cells as secreted protein
Purified recombinant SARS-CoV-2 BA.1 (B.1.1.529.1) Spike protein (trimerisation domain and C-terminal hexa histidine-tag) expressed in mammalian HEK293F cells as secreted protein
